Meet ACE2!

ACE2 is short for Angiotensin-Converting Enzyme 2, because it “converts” the peptide angiotensin II into angiotensin. Angiotensin II tells your body’s blood vessels to get smaller which raises blood pressure, but angiotensin tells them to get larger and lowers blood pressure. In this way, ACE2’s job is to lower blood pressure.

Diagram showing ACE2 converting angiotensin II into angiotensin. Angiotensin II triggers higher blood pressure, while angiotensin triggers lower blood pressure.

ACE2 lives in the membranes of cells in human lungs, small intestines, arteries and veins. It stretches from the inside of the cell, through the membrane, to the outside of the cell. The piece of ACE2 that lives outside of the cell is the piece that converts angiotensins, which allows the angiotensin signals to be spread easily from cell to cell. 

Three-dimensional structure model of ACE2. One helix at the bottom is colored pink and is responsible for anchoring ACE2 to the cell membrane. The cleft where angiotensin II enters/angiotensin exits is pointed out. There is a Zinc ion in this cleft which helps with the reaction.

The viruses SARS-CoV and SARS-CoV-2 recognize good host cells by looking for ACE2. The viruses use their Spike proteins to bind to ACE2, then begin their invasion into the host cell (read about Spike here!). This explains why COVID-19 greatly impacts the respiratory system, since ACE2 is found abundantly in lung cells. Some studies have also shown that patients taking drugs that activate ACE2, intended to lower blood pressure, can be risky for SARS or COVID-19 infections (though many factors influence this risk).

Diagram showing ACE2 in the cell membrane interacting with the Spike protein of a coronavirus.
ACE2 binds the coronavirus Spike protein.
Three-dimensional structure model of ACE2 binding to the SARS-CoV-2 spike protein.

Hamming, I., Timens, W., Bulthuis, M. L., Lely, A. T., Navis, G., & van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of pathology203(2), 631–637.

Chan, K. K., Dorosky, D., Sharma, P., Abbasi, S. A., Dye, J. M., Kranz, D. M., Herbert, A. S., & Procko, E. (2020). Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science (New York, N.Y.)369(6508), 1261–1265.

One Reply to “Meet ACE2!”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s